Lausanne, Switzerland, November 15, 2007 - Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist in oncology and serious medical conditions, today presented Chinese scientist Dr KONG Weijia with the “2007 Debiopharm-CCRF China Award” for her outstanding and innovative research work on “Cholesterol-lowering efficacy of berberine : molecular mechanism, clinical application and development of analogs or prodrugs”.
